Skip to main content
Clinical Trials/ITMCTR2200006610
ITMCTR2200006610
Not yet recruiting
Phase 1

Evaluation of therapeutic effect of thumbtack needle on high altitude insomnia

Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences0 sitesTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
insomonia disorder
Sponsor
Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • 1\. Insomnia was diagnosed according to the insomnia disorder standard of the fifth edition of the diagnostic and Statistical Manual of mental diseases (DSM\-V); 2\. insomniac group inclusion criteria: ? Patients with insomnia as the main complaint, who meet the above diagnostic criteria and have typical symptom groups of insomnia; ? PSQI \= 8 points; ? Age \= 18 years old; ? They volunteered to participate in this study and signed informed consent.

Exclusion Criteria

  • ? Those who combine with diseases that have not been effectively controlled or are extremely serious, such as persistent pain, malignant tumors, cardiovascular and cerebrovascular diseases, neuroendocrine diseases, neuromuscular diseases and digestive tract diseases caused by various reasons, resulting in insomnia disorders; Comorbid personality disorder or mental retardation; ? Those with severe depression and anxiety (SAS \> 70; Self rating Depression Scale (SDS)\>73\); ? Use alcohol and / or other drugs or dependent drugs; ? Have suffered from depression or other mental diseases within 6 months before enrollment; ? Those who were treated with insomnia drugs within 1 month before enrollment; ? Those who participated in any other clinical trial within 1 month before baseline; ? Pregnant and lactating patients. ? Those who cannot cooperate with the treatment.

Outcomes

Primary Outcomes

Not specified

Similar Trials